Active specific immunotherapy of minimal residual tumor: excision plus neuraminidase-treated tumor cells.
D000230:Adenocarcinoma / Q000601:surgery / Q000628:therapy*; D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D005260:Female; D005354:Fibrosarcoma / Q000139:chemically induced / Q000601:surgery / Q000628:therapy*; D007167:Immunotherapy; D008325:Mammary Neoplasms, Experimental; D008545:Melanoma / Q000601:surgery / Q000628:therapy*; D008748:Methylcholanthrene; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008937:Mitomycins / Q000494:pharmacology*; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental; D009439:Neuraminidase / Q000494:pharmacology*; D012513:Sarcoma, Experimental; D014184:Transplantation, Homologous; D014734:Vibrio cholerae
D008937:Mitomycins; D008748:Methylcholanthrene; D009439:Neuraminidase